Literature DB >> 15210144

Synthesis and antiangiogenic activity of thioacetal artemisinin derivatives.

Sangtae Oh1, In Howa Jeong, Chan Mug Ahn, Woon-Seob Shin, Seokjoon Lee.   

Abstract

Various thioacetal artemisinin derivatives can inhibit the angiogenesis and might be angiogenesis inhibitors. In particular, 10 alpha-phenylthiodihydroartemisinins (5), 10 beta-benzenesulfonyl-9-epi-dihydroartemisinin (11) and 10 alpha-mercaptodihydroartemisinin (13) exhibit strong growth inhibition activity against HUVEC proliferation. Compound 11 have a good inhibitiory activity upon HUVEC tube formation, and 5 and 11 show a strong inhibitory effect on angiogenesis using CAM assay at 5 microg/egg by 90%.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15210144     DOI: 10.1016/j.bmc.2004.05.013

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  3 in total

Review 1.  Development of artemisinin compounds for cancer treatment.

Authors:  Henry C Lai; Narendra P Singh; Tomikazu Sasaki
Journal:  Invest New Drugs       Date:  2012-08-31       Impact factor: 3.850

2.  Malaria-infected mice live until at least day 30 after a new artemisinin-derived thioacetal thiocarbonate combined with mefloquine are administered together in a single, low, oral dose.

Authors:  Alexander M Jacobine; Jennifer R Mazzone; Rachel D Slack; Abhai K Tripathi; David J Sullivan; Gary H Posner
Journal:  J Med Chem       Date:  2012-08-27       Impact factor: 7.446

3.  Antimalarial activity of thiophenyl- and benzenesulfonyl-dihydroartemisinin.

Authors:  Seokjoon Lee; Sangtae Oh; Gab-Man Park; Tong-Soo Kim; Jae-Sook Ryu; Han-Kyu Choi
Journal:  Korean J Parasitol       Date:  2005-09       Impact factor: 1.341

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.